Sarepta Therapeutics, Inc
Filings
Newest firstThe annual , the quarterly and the filed between them when something material happens.
- Sep 238-KMaterial agreement1.01
- Aug 713GPassive stake of 5% or more (13G)
- Aug 58-KResults of operations2.029.01
- Aug 510-QQuarterly report
- Jul 278-KOfficer or director change and Regulation FD disclosure5.027.019.01
- Jun 48-KOfficer or director change and shareholder vote5.025.079.01
- May 68-KResults of operations2.029.01
- May 610-QQuarterly report
- Mar 210-KAnnual report
- Feb 258-KOfficer or director change5.02
- Feb 258-KResults of operations2.029.01
- Jan 128-KResults of operations2.029.01
- Dec 19, 20258-KMaterial agreement and new debt or obligation1.012.039.01
- Dec 11, 20258-KUnregistered sale of shares and other events3.028.019.01
- Dec 8, 20258-KOfficer or director change5.029.01
- Nov 6, 202510-QQuarterly report
- Nov 3, 20258-KResults of operations2.029.01
- Aug 29, 20258-KMaterial agreement and other events1.012.038.019.01
- Aug 21, 20258-KUnregistered sale of shares3.02
- Aug 13, 20258-KOfficer or director change5.02
- Aug 6, 202510-QQuarterly report
- Jul 21, 20258-KOther events8.01
- Jul 16, 20258-KResults of operations and officer or director change2.022.055.029.01
- Jun 6, 20258-KOfficer or director change and shareholder vote5.025.079.01
- May 6, 202510-QQuarterly report
- Feb 28, 202510-KAnnual report
- Feb 26, 20258-KResults of operations2.029.01
- Feb 14, 20258-KMaterial agreement and new debt or obligation1.012.039.01
- Jan 13, 20258-KResults of operations2.029.01
- Nov 26, 20248-KMaterial agreement1.01
- Nov 6, 202410-QQuarterly report